Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Ye Z, Huang J, Zhou L, Chen S, Wang Z, Ma L, Wang D, Wang G, Wang S, Liang C, Qiu S, Gu X, Liu J, Weng Z, Wu C, Wei Q, Xie L, Wu W, Cheng Y, Hu J, Wang Z, Zeng X. Ye Z, et al. Among authors: weng z. Urology. 2019 Jul;129:172-179. doi: 10.1016/j.urology.2019.02.030. Epub 2019 Mar 14. Urology. 2019. PMID: 30880074 Clinical Trial.
Efficacy of daily low-dose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial--treatment of interstitial cystitis/painful bladder syndrome with low-dose sildenafil.
Chen H, Wang F, Chen W, Ye Xt, Zhou Q, Shao F, Dai S, Yu Z, Zhang Y, Li C, Chen B, Weng Z. Chen H, et al. Among authors: weng z. Urology. 2014 Jul;84(1):51-6. doi: 10.1016/j.urology.2014.02.050. Epub 2014 May 14. Urology. 2014. PMID: 24837447 Clinical Trial.
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Liao L, Liu Q, Cong H, Xu Z, Li E, Weng Z, Jiang H, Liu B, Huang X, Xia S, Wen W, Wu J, Shi G, Wang Y, Li P, Yu Y, Fang Z, Zheng J, Tian Y, Shang D, Li H, Huang Z, Zhou L, Xiao Y, Zhang Y, Wang J, Zhang X, Zhang P, Wang D, Zhang X, Xie K, Wang B, Ma L, Tian X, Chen L, Dong J. Liao L, et al. Among authors: weng z. Front Pharmacol. 2022 Feb 18;13:840695. doi: 10.3389/fphar.2022.840695. eCollection 2022. Front Pharmacol. 2022. PMID: 35250586 Free PMC article.
Sacral Neuromodulation Using a Novel Device with a Six-contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial.
Liao L, Zhou Z, Chen G, Xu Z, Huang B, Chong T, Chen Q, Wei Z, Shen B, Chen Z, Ling Q, Weng Z, Jiang H, Shi B, Li Y, Wang Y. Liao L, et al. Among authors: weng z. Eur Urol Focus. 2022 Nov;8(6):1823-1830. doi: 10.1016/j.euf.2022.04.006. Epub 2022 May 4. Eur Urol Focus. 2022. PMID: 35525837 Clinical Trial.
Reply: To PMID 24837446.
Chen H, Weng Z. Chen H, et al. Among authors: weng z. Urology. 2014 Jul;84(1):56. doi: 10.1016/j.urology.2014.02.057. Epub 2014 May 14. Urology. 2014. PMID: 24837448 No abstract available.
1,602 results